Superior Planning LLC’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
Other funds holding ACAD
Superior Planning LLC's ACAD Position: Q3 2026 in Review
Superior Planning LLC opened a new position in Acadia Pharmaceuticals (ACAD) in Q3 2026: 1 share worth $20. The stake represents ﹤0.01% of the portfolio and ranks #2129 among its holdings.
268 funds tracked by Wall St. Rank hold ACAD as of Q3 2026.
- Superior Planning LLC held 1 share of Acadia Pharmaceuticals worth $20 as of Q3 2026.
- Acadia Pharmaceuticals was a new Superior Planning LLC position in Q3 2026.
- Acadia Pharmaceuticals made up ﹤0.01% of Superior Planning LLC's portfolio in Q3 2026, its #2129 holding.
- 268 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2026.
Based on Superior Planning LLC's 13F filing for Q3 2026, filed 12 Nov 2026.